Amgen's $727 Million Trading Day Sees 100th Ranking Amidst Three-Day Decline
Generated by AI AgentAinvest Market Brief
Wednesday, Mar 26, 2025 7:41 pm ET1min read
AMGN--
On March 26, 2025, Amgen's trading volume reached $727 million, ranking 100th in the day's stock market. Amgen's stock price fell by 0.37%, marking the third consecutive day of decline, with a total decrease of 3.27% over the past three days.
Fresenius has received clearance to target Amgen's Prolia with its biosimilars. This development could potentially impact Amgen's market share and revenue from Prolia, a key drug in its portfolio. Investors are closely monitoring the situation as it may influence Amgen's future financial performance and stock price.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet